Education
About Us
Working with TipRanks
Follow Us
AstraZeneca PLC (AZN)
NYSE:AZN
Total Valuation
AstraZeneca has a market cap or net worth of $323.92B. The enterprise value is $343.21B.
Market Cap$323.92B
Enterprise Value$343.21B
Share Statistics
AstraZeneca has 1,550,944,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,550,944,600
Owned by Insiders0.02%
Owned by Institutions<0.01%
Financial Efficiency
AstraZeneca’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 13.04%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)13.04%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee622.90K
Profits Per Employee131.52K
Employee Count94,300
Asset Turnover0.51
Inventory Turnover1.62
Valuation Ratios
The current PE Ratio of AstraZeneca is 31.6. AstraZeneca’s PEG ratio is 0.58.
PE Ratio31.6
PS Ratio4.90
PB Ratio5.91
Price to Fair Value5.91
Price to FCF33.17
Price to Operating Cash Flow21.87
PEG Ratio0.58
Income Statement
In the last 12 months, AstraZeneca had revenue of 58.74B and earned 10.22B in profits. Earnings per share was 6.60.
Revenue58.74B
Gross Profit48.11B
Operating Income13.74B
Pretax Income12.40B
Net Income10.22B
EBITDA19.83B
Earnings Per Share (EPS)6.60
Cash Flow
In the last 12 months, operating cash flow was 14.57B and capital expenditures -4.33B, giving a free cash flow of 10.25B billion.
Operating Cash Flow14.57B
Free Cash Flow10.25B
Free Cash Flow per Share6.61
Dividends & Yields
AstraZeneca pays an annual dividend of $1.025, resulting in a dividend yield of 1.72%
Dividend Per Share$1.025
Dividend Yield1.72%
Payout Ratio34.39%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.08
52-Week Price Change47.52%
50-Day Moving Average187.25
200-Day Moving Average162.90
Relative Strength Index (RSI)67.12
Average Volume (3m)3.76K
Important Dates
AstraZeneca upcoming earnings date is Apr 29, 2026, Before Open (Confirmed).
Last Earnings DateFeb 10, 2026
Next Earnings DateApr 29, 2026
Ex-Dividend Date―
Financial Position
AstraZeneca as a current ratio of 0.94, with Debt / Equity ratio of 60.87%
Current Ratio0.94
Quick Ratio0.72
Debt to Market Cap0.10
Net Debt to EBITDA1.21
Interest Coverage Ratio8.11
Taxes
In the past 12 months, AstraZeneca has paid 2.17B in taxes.
Income Tax2.17B
Effective Tax Rate0.17
Enterprise Valuation
AstraZeneca EV to EBITDA ratio is 15.71, with an EV/FCF ratio of 35.93.
EV to Sales5.30
EV to EBITDA15.71
EV to Free Cash Flow35.93
EV to Operating Cash Flow21.37
Balance Sheet
AstraZeneca has $5.74B in cash and marketable securities with $29.62B in debt, giving a net cash position of -$23.88B billion.
Cash & Marketable Securities$5.74B
Total Debt$29.62B
Net Cash-$23.88B
Net Cash Per Share-$15.40
Tangible Book Value Per Share-$6.69
Margins
Gross margin is 78.23%, with operating margin of 23.40%, and net profit margin of 17.41%.
Gross Margin78.23%
Operating Margin23.40%
Pretax Margin21.11%
Net Profit Margin17.41%
EBITDA Margin33.76%
EBIT Margin24.00%
Analyst Forecast
The average price target for AstraZeneca is $192.07, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$192.07
Price Target Upside-7.93% Downside
Analyst ConsensusStrong Buy
Analyst Count16
Revenue Growth Forecast―
EPS Growth Forecast―